Biotech

All Articles

Kairos goes social with $6M IPO to finance trials of cancer medicine

.With a triad of biotechs striking the Nasdaq on Friday, it was easy to miss out on a smaller-scale ...

Vaccine as well as Keytruda combo efficient in squamous tissue carcinoma

.Immune gate inhibitors are actually the superheroes of cancer treatment. Medicines like Bristol Mye...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, shooting...

Regeneron's Opdualag competitor presents 57% reaction fee

.Regeneron is actually back with long-term follow-up for its own LAG-3 inhibitor and also PD-1 preve...

AstraZeneca articles records on internal rivals to AbbVie, Pfizer ADCs

.AstraZeneca has actually shared a very early examine the efficiency of its internal antibody-drug c...

iTeos- GSK's TIGIT star shows significant remodeling

.After announcing a period 3 launch based on beneficial midstage end results, iTeos as well as GSK a...

More collaborative FDA can easily speed up unusual health condition R&ampD: file

.The FDA needs to be even more available and also joint to let loose a rise in commendations of unco...

Zenas, MBX, Bicara head to Nasdaq in warm day for biotech IPOs

.It is actually an uncommonly hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX as wel...

Atea's COVID antiviral fails to stop hospitalizations in period 3

.Atea Pharmaceuticals' antiviral has actually fallen short another COVID-19 test, yet the biotech st...

Neurocrine's offer to save schizophrenia possibility stops working

.Neurocrine Biosciences' mental illness system pivot has fallen short. The biotech was actually inca...